Generic Drugmakers Fall Short for Poorest Patients

• Analysis examined 50 medicines from five large manufacturers
• Some essential drugs still inaccessible despite price declines

 Efforts by major generic drugmakers to expand access to essential medicines have fallen short for many of the world’s poorest patients, a new study found.

Only one of out 50 products made by five large generic drug makers — Cipla Ltd., Hikma Pharmaceuticals Plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Viatris Inc. — had a pricing strategy that took into account a patient’s ability to pay in low-to-middle income nations, according the report from the Access to Medicine Foundation.

https://www.bloomberg.com/news/articles/2023-09-26/generic-drugmakers-fall-short-for-poorest-patients-report-says